Simple Science

Cutting edge science explained simply

# Biology# Neuroscience

New Insights into ALS and Brain Injury

Research reveals links between ALS, C9orf72 mutation, and traumatic brain injury.

― 5 min read


ALS, C9orf72, and BrainALS, C9orf72, and BrainInjury LinksALS.genetics and traumatic brain injury inResearch explores connections between
Table of Contents

Amyotrophic lateral sclerosis (ALS) is a serious disease affecting the nerve cells in the brain and spinal cord. It causes the gradual loss of muscle control, leading to weakness and eventually paralysis. Unfortunately, there are no effective treatments available for ALS at this time.

Causes of ALS

ALS targets specific nerve cells known as Motor Neurons. When these neurons die, the brain cannot communicate with the muscles, resulting in muscle wasting. The death of these cells is linked to several processes within the cell, such as the handling of RNA, how proteins are broken down, and the stability of the cell's structure. About 10% of ALS cases are inherited through family genes, while the other cases seem to arise from a mix of genes and environmental factors.

A significant percentage of individuals with ALS also face another condition called frontotemporal dementia (FTD). This condition affects the parts of the brain related to thinking and behavior, often leading to difficulties with speaking and planning. A major genetic factor behind both ALS and FTD is a repetition of a six-letter DNA sequence found in the C9orf72 gene. This genetic change is present in a considerable number of ALS and FTD cases.

The Effects of C9orf72 Mutation

People with the C9orf72 mutation can show a variety of symptoms. Some may only experience ALS symptoms, others may only show signs of FTD, and some may have both. The age at which symptoms appear can also vary greatly, ranging from the 40s to 90s. In rare situations, individuals with this mutation may never show symptoms at all. The length of the repeated DNA sequence doesn't directly relate to the severity of the disease, making it a complex area of study.

The Role of Traumatic Brain Injury (TBI)

A blow to the head or body, known as traumatic brain injury (TBI), is another factor linked with the risk of developing neurodegenerative diseases like ALS and FTD. TBI is common, affecting millions of people each year. It can lead to a variety of symptoms, some of which can last for a long time. Even minor injuries can cause long-term problems in the brain. This is evident in a condition called chronic traumatic encephalopathy (CTE), which arises from repeated brain injuries.

One notable connection between TBI and ALS/FTD is the presence of TDP-43, a protein that tends to misfold and accumulate in the brains of affected individuals. Missteps in TDP-43 are found in almost all cases of ALS and a significant number of FTD cases. Similar aggregations of this protein have also been noted in cases of TBI and CTE, leading researchers to question whether the processes causing TDP-43 issues in ALS and TBI are related.

Investigating C9orf72 ALS and TBI

To learn more about the links between ALS caused by C9orf72 mutation and TBI, researchers have developed laboratory models using human cells. These models utilize induced pluripotent stem cells (iPSCs) derived from ALS patients to create motor neurons that can be subjected to controlled injuries.

Experiments have shown that motor neurons from individuals with the C9orf72 mutation are more likely to be damaged by mild injuries compared to control neurons. When subjected to severe trauma, these neurons not only showed signs of degeneration but also displayed changes in TDP-43 protein behavior. On the other hand, control neurons were largely unaffected by the same trauma.

How Traumatic Injury Affects Motor Neurons

In laboratory studies, researchers applied mild and severe injuries to cultured neurons and observed their responses. They found that while control neurons generally showed resilience to trauma, the C9orf72 motor neurons displayed a significant drop in survival following severe injury. Some of this damage could be mitigated by using a specific treatment that targets the harmful genetic change, revealing potential pathways for future treatment.

Understanding TDP-43 and Its Role

When researchers looked into the behavior of TDP-43 after injury, they discovered that in C9orf72 motor neurons, the protein tended to mislocalize or move out of the nucleus in response to trauma. This mislocalization was not seen in control neurons. Moreover, TDP-43 mislocalization persisted for an extended period in the C9orf72 neurons, suggesting a failure to return to normal function after being stressed.

In contrast, control neurons briefly showed TDP-43 mislocalization after mild injury but returned to normal within half an hour. The prolonged issue in C9orf72 neurons hinted that the mutation impacted their response to injury.

The Impact of Repeated Mild Injuries

When the researchers further examined the effects of repeatedly applying mild injuries on C9orf72 motor neurons, they noticed a concerning trend. After a second mild injury, the survival of these neurons dropped significantly. This was not the case for control neurons. The repeated trauma led to ongoing TDP-43 mislocalization and increased levels of abnormal splicing of specific messenger RNAs, indicating that the effects of injury could compound the existing vulnerability.

Implications for Treatment and Future Research

The research highlights the complex relationship between genetic factors and environmental influences in conditions like ALS. Understanding how TBI interacts with genetic mutations in ALS can open up pathways for treatment. The use of iPSC models offers a valuable way to study these interactions and develop potential therapies.

Researchers recognize that while this study provides insight, it also has limitations. For instance, focusing solely on motor neurons does not address the roles of other cell types affected by TBI. Additionally, the physical nature of traumatic injuries varies greatly, and different types of trauma may cause different responses in the nervous system.

Conclusion

The findings from this research point to the need for further exploration into the processes that link ALS, particularly cases with the C9orf72 mutation, to Traumatic Brain Injuries. By better understanding these relationships, we can work towards developing effective preventive measures and treatments. The interplay between genetic factors and external injuries illustrates the complexity of ALS and the ongoing challenges faced in addressing neurodegenerative diseases.

Original Source

Title: Traumatic injury causes selective degeneration and TDP-43 mislocalization in human iPSC-derived C9orf72-associated ALS/FTD motor neurons

Abstract: A hexanucleotide repeat expansion (HRE) in C9orf72 is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, patients with the HRE exhibit a wide disparity in clinical presentation and age of symptom onset suggesting an interplay between genetic background and environmental stressors. Neurotrauma as a result of traumatic brain or spinal cord injury has been shown to increase the risk of ALS/FTD in epidemiological studies. Here, we combine patient-specific induced pluripotent stem cells (iPSCs) with a custom-built device to deliver biofidelic stretch trauma to C9orf72 patient and isogenic control motor neurons (MNs) in vitro. We find that mutant but not control MNs exhibit selective degeneration after a single incident of severe trauma, which can be partially rescued by pretreatment with a C9orf72 antisense oligonucleotide. A single incident of mild trauma does not cause degeneration but leads to cytoplasmic accumulation of TDP-43 in C9orf72 MNs. This mislocalization, which only occurs briefly in isogenic controls, is eventually restored in C9orf72 MNs after 6 days. Lastly, repeated mild trauma ablates the ability of patient MNs to recover. These findings highlight alterations in TDP-43 dynamics in C9orf72 ALS/FTD patient MNs following traumatic injury and demonstrate that neurotrauma compounds neuropathology in C9orf72 ALS/FTD. More broadly, our work establishes an in vitro platform that can be used to interrogate the mechanistic interactions between ALS/FTD and neurotrauma.

Authors: Evangelos Kiskinis, E. J. Martin, C. Santacruz, A. Mitevska, I. E. Jones, G. Krishnan, F.-B. Gao, J. D. Finan

Last Update: 2024-03-26 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.03.21.586073

Source PDF: https://www.biorxiv.org/content/10.1101/2024.03.21.586073.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles